These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 32971903

  • 1. An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.
    López-Martínez A, Soblechero-Martín P, de-la-Puente-Ovejero L, Nogales-Gadea G, Arechavala-Gomeza V.
    Genes (Basel); 2020 Sep 22; 11(9):. PubMed ID: 32971903
    [Abstract] [Full Text] [Related]

  • 2. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R.
    Biol Rev Camb Philos Soc; 2021 Apr 22; 96(2):716-730. PubMed ID: 33269537
    [Abstract] [Full Text] [Related]

  • 3. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L, Huguet-Lachon A, Gourdon G.
    PLoS One; 2015 Apr 22; 10(9):e0137620. PubMed ID: 26339785
    [Abstract] [Full Text] [Related]

  • 4. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
    Nutter CA, Kidd BM, Carter HA, Hamel JI, Mackie PM, Kumbkarni N, Davenport ML, Tuyn DM, Gopinath A, Creigh PD, Sznajder ŁJ, Wang ET, Ranum LPW, Khoshbouei H, Day JW, Sampson JB, Prokop S, Swanson MS.
    Brain; 2023 Oct 03; 146(10):4217-4232. PubMed ID: 37143315
    [Abstract] [Full Text] [Related]

  • 5. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM, van Cruchten RTP, Willemse M, Wansink DG.
    PLoS One; 2019 Oct 03; 14(5):e0217317. PubMed ID: 31116797
    [Abstract] [Full Text] [Related]

  • 6. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
    Chau A, Kalsotra A.
    Dev Dyn; 2015 Mar 03; 244(3):377-90. PubMed ID: 25504326
    [Abstract] [Full Text] [Related]

  • 7. AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.
    Stepniak-Konieczna E, Konieczny P, Cywoniuk P, Dluzewska J, Sobczak K.
    Nucleic Acids Res; 2020 Mar 18; 48(5):2531-2543. PubMed ID: 31965181
    [Abstract] [Full Text] [Related]

  • 8. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
    Neault N, Ravel-Chapuis A, Baird SD, Lunde JA, Poirier M, Staykov E, Plaza-Diaz J, Medina G, Abadía-Molina F, Jasmin BJ, MacKenzie AE.
    Int J Mol Sci; 2023 Feb 14; 24(4):. PubMed ID: 36835205
    [Abstract] [Full Text] [Related]

  • 9. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
    Kuyumcu-Martinez NM, Cooper TA.
    Prog Mol Subcell Biol; 2006 Feb 14; 44():133-59. PubMed ID: 17076268
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.
    Kim YK, Mandal M, Yadava RS, Paillard L, Mahadevan MS.
    Hum Mol Genet; 2014 Jan 15; 23(2):293-302. PubMed ID: 24001600
    [Abstract] [Full Text] [Related]

  • 11. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy.
    Chakraborty M, Sellier C, Ney M, Pascal V, Charlet-Berguerand N, Artero R, Llamusi B.
    Dis Model Mech; 2018 Apr 23; 11(4):. PubMed ID: 29592894
    [Abstract] [Full Text] [Related]

  • 12. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y, Kino Y, Sasagawa N, Nishino I, Ishiura S.
    Neuromuscul Disord; 2007 Apr 23; 17(4):306-12. PubMed ID: 17331722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A, Rinaldi F, Catalli C, Vergani L, Bonifazi E, Romeo V, Loro E, Viola A, Angelini C, Novelli G.
    J Med Genet; 2008 Oct 23; 45(10):639-46. PubMed ID: 18611984
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
    Hino S, Kondo S, Sekiya H, Saito A, Kanemoto S, Murakami T, Chihara K, Aoki Y, Nakamori M, Takahashi MP, Imaizumi K.
    Hum Mol Genet; 2007 Dec 01; 16(23):2834-43. PubMed ID: 17728322
    [Abstract] [Full Text] [Related]

  • 17. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
    Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA.
    J Clin Invest; 2007 Oct 01; 117(10):2802-11. PubMed ID: 17823658
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.